A single-center experience in use of tocilizumab in COVID-19 pneumonia in India.

Joshi, Aditya; Kumar M, Krishna; Kumar, Abhishek; Nair, Ranjith K; Singh, Jasdeep; Chakrabarti, Ritwik; Kapoor, Rajan

Joshi, Aditya; Kumar M, Krishna; Kumar, Abhishek; Nair, Ranjith K; Singh, Jasdeep; Chakrabarti, Ritwik; Kapoor, Rajan.

Afiliação

Joshi A; Assistant Professor (Anaesthesia), Command Hospital (Eastern Command), Kolkata, India.
Kumar M K; Assistant Professor (Anaesthesia), Command Hospital (Eastern Command), Kolkata, India.
Kumar A; Associate Professor (Medicine), Command Hospital (Eastern Command), Kolkata, India.
Nair RK; Professor (Medicine), Command Hospital (Eastern Command), Kolkata, India.
Singh J; Assistant Professor (Pathology), Command Hospital (Eastern Command), Kolkata, India.
Chakrabarti R; Assistant Professor (Radiology), Command Hospital (Eastern Command), Kolkata, India.
Kapoor R; Professor (Medicine), Command Hospital (Eastern Command), Kolkata, India.

Med J Armed Forces India ; 77: S296-S304, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34334897

Palavras-chave

COVID-19; Hyperinflammatory; Interleukin-6; Pneumonia; Tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Med J Armed Forces India Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google